Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ideaya Biosciences Inc
(NQ:
IDYA
)
37.76
-0.35 (-0.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
677,201
Open
37.94
Bid (Size)
37.76 (1)
Ask (Size)
40.33 (1)
Prev. Close
38.11
Today's Range
37.24 - 38.28
52wk Range
23.41 - 47.73
Shares Outstanding
48,390,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024
August 06, 2024
IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
August 03, 2024
Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,...
Via
Talk Markets
Performance
YTD
+7.21%
+7.21%
1 Month
-7.65%
-7.65%
3 Month
-6.35%
-6.35%
6 Month
-14.20%
-14.20%
1 Year
+40.27%
+40.27%
More News
Read More
MarketBeat Week in Review – 7/15 - 7/19
July 20, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Positive News is Driving This Cancer Drug Maker’s Stock Higher
July 15, 2024
Via
MarketBeat
Unveiling 5 Analyst Insights On IDEAYA Biosciences
May 08, 2024
Via
Benzinga
Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
March 08, 2024
Via
Benzinga
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
February 21, 2024
Via
Benzinga
Recap: IDEAYA Biosciences Q4 Earnings
February 20, 2024
Via
Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 10, 2024
Via
Benzinga
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
July 10, 2024
Via
Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 08, 2024
Via
Benzinga
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
July 08, 2024
Via
Benzinga
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
July 08, 2024
Via
Benzinga
Why Ideaya Biosciences Just Made Its Most Bullish Move Since March
July 08, 2024
Via
Investor's Business Daily
Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
July 08, 2024
Via
Benzinga
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
January 26, 2024
Via
Benzinga
IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24
January 24, 2024
Via
Investor Brand Network
IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19
January 19, 2024
Via
Investor Brand Network
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
January 25, 2024
Via
Benzinga
Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine
January 11, 2024
Via
Talk Markets
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
January 10, 2024
Via
Benzinga
8 Analysts Have This to Say About IDEAYA Biosciences
November 30, 2023
Via
Benzinga
The Latest Analyst Ratings for IDEAYA Biosciences
November 13, 2023
Via
Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.